The contention that the adenosine modulation system is mostly engaged in allostatic control rather than homeostatic regulation still requires to be directly demonstrated using these quad-AR-KO mice: it will be of interest to confirm if quad-AR-KO mice will respond differently to chronic challenges such as diabetes, hypertension, cancer, or in animal models of neurodegenerative or psychiatric disorders. This evidence concerns the gene AR and cancer.